Comparative inhalation toxicity of multi-wall carbon nanotubes, graphene, graphite nanoplatelets and low surface carbon black

Abstract

BackgroundCarbon nanotubes, graphene, graphite nanoplatelets and carbon black are seemingly chemically identical carbon-based nano-materials with broad technological applications. Carbon nanotubes and carbon black possess different inhalation toxicities, whereas little is known about graphene and graphite nanoplatelets.MethodsIn order to compare the inhalation toxicity of the mentioned carbon-based nanomaterials, male Wistar rats were exposed head-nose to atmospheres of the respective materials for 6 hours per day on 5 consecutive days. Target concentrations were 0.1, 0.5, or 2.5 mg/m3 for multi-wall carbon nanotubes and 0.5, 2.5, or 10 mg/m3 for graphene, graphite nanoplatelets and low-surface carbon black. Toxicity was determined after end of exposure and after three-week recovery using broncho-alveolar lavage fluid and microscopic examinations of the entire respiratory tract.ResultsNo adverse effects were observed after inhalation exposure to 10 mg/m3 graphite nanoplatelets or relatively low specific surface area carbon black. Increases of lavage markers indicative for inflammatory processes started at exposure concentration of 0.5 mg/m3 for multi-wall carbon nanotubes and 10 mg/m3 for graphene. Consistent with the changes in lavage fluid, microgranulomas were observed at 2.5 mg/m3 multi-wall carbon nanotubes and 10 mg/m3 graphene. In order to evaluate volumetric loading of the lung as the key parameter driving the toxicity, deposited particle volume was calculated, taking into account different methods to determine the agglomerate density. However, the calculated volumetric load did not correlate to the toxicity, nor did the particle surface burden of the lung.ConclusionsThe inhalation toxicity of the investigated carbon-based materials is likely to be a complex interaction of several parameters. Until the properties which govern the toxicity are identified, testing by short-term inhalation is the best option to identify hazardous properties in order to avoid unsafe applications or select safer alternatives for a given application.

Toward achieving harmonization in a nanocytotoxicity assay measurement through an interlaboratory comparison study

“…For example, in vivo studies are often carried out with lower doses per lung surface (excluding overload experiments). For various carbonaceous materials, it has been demonstrated that at similar doses, carbon black and graphite have no effect (0.1 or 0.03 µg/cm 2 , respectively; an estimate of the rat lung surface area 0.3 m 2 was used in this calculation (Brown et al, 2005)), but graphene and multiwall carbon nanotubes do have an effect (0.03 or 0.01 µg/cm 2 , respectively (Ma-Hock et al, 2013)). Moreover, in vivo investigations have shown that both the dosing rate and the delivered dose are responsible for toxicological effects.…”

Route-dependent systemic and local immune effects following exposure to solutions prepared from titanium dioxide nanoparticles

“…Levels of statistical significance: *p 0.05 and **p 0.01 compared to appropriate control group. between the 'synthetic' and 'biological' identities of nanoparticle formulations and observed in vivo effects (Ma-Hock et al, 2013). Lastly, human exposure to nanoparticles rarely, if ever, occurs to well-defined nanoparticle preparations.…”

Nanomaterials in the Environment: Perspectives on in Vivo Terrestrial Toxicity Testing

“…The toxicity of MWCNTs is more adverse in the case of inhalation as compared to oral exposure. Rats exposed to 2.5 mg/m 3 MWCNTs for 6 h/day during 5 consecutive days using a head-nose system demonstrated signs of pulmonary toxicity such as, microgranulomas and diffuse alveolar histiocytosis (Ma-Hock et al, 2013). After a 13-week exposure period, the inhalation of 2.5 mg/m 3 MWCNTs induced systemic inflammation and histopathological abnormalities in the lungs, lymph nodes, nasal cavity, larynx, and trachea (Ma-Hock et al, 2009).…”